Lamivudine-refractory, chronic hepatitis B patients can be safely switched to entecavir 1.0 mg daily without risk of ALT flare

---

Boyer T., Sherman M., Yurdaydin C., Sollano J., Silva M., Chen L., ...More

6th International Workshop on Adverse Drug Reactions and Lipodystrophy in HIV, Washington, Kiribati, 25 - 28 October 2004, vol.9, (Summary Text)

• Publication Type: Conference Paper / Summary Text
• Volume: 9
• City: Washington
• Country: Kiribati
• Ankara University Affiliated: No